Lisinopril Cost in Pennsylvania 2026

What Is the Cash Price of Lisinopril in Pennsylvania?

Generic lisinopril averages about $8 per month at Pennsylvania retail pharmacies when paid out of pocket in 2026. Prices vary by chain, dose, and quantity, so shopping around matters. At Walmart and Costco pharmacies across Pennsylvania, 30 tablets of 10 mg lisinopril have been listed at $4 or under with a discount card applied.

The manufacturer list price for older branded ACE inhibitor products sits near $50 per month, but no clinician in Pennsylvania prescribes brand-name lisinopril for routine hypertension management when a generic tablet costs a fraction of that price. Generic lisinopril received FDA approval as a bioequivalent substitute and carries the same pharmacokinetic and pharmacodynamic profile as the original formulation [1].

Lisinopril belongs to the ACE inhibitor class. It blocks angiotensin-converting enzyme, reducing the formation of angiotensin II and thereby lowering peripheral vascular resistance [2]. The ALLHAT trial (N=33,357) compared lisinopril against chlorthalidone and amlodipine for high-risk hypertensive adults and found no significant difference in combined fatal coronary heart disease or nonfatal MI (relative risk 0.99 to 95% CI 0.91, 1.08) [3]. That trial, published in JAMA 2002, remains the largest head-to-head antihypertensive study and still informs the JNC prescribing framework used by Pennsylvania clinicians today [3].

Dose also affects price. A 30-tablet supply of 5 mg costs roughly the same as 10 mg or 20 mg at most Pennsylvania pharmacies because all generic strengths sit in the same low-cost tier. The 40 mg tablet may carry a slightly higher cash price at independent pharmacies, though chain pharmacies generally keep it flat.

To get the lowest cash price, call at least three Pennsylvania pharmacies before filling. Prices at CVS, Rite Aid, Giant Pharmacy, and Walmart can differ by $3, $6 per month on the same strength with the same discount card applied [4].

Does Pennsylvania Medicaid Cover Lisinopril?

Pennsylvania Medicaid (Medical Assistance, or MA) covers generic lisinopril for enrolled adults without requiring prior authorization in most clinical situations. It appears on the Pennsylvania MA Preferred Drug List (PDL) as a preferred ACE inhibitor [5].

Coverage applies across the main MA managed care organizations operating in Pennsylvania, including Highmark Health Options, Keystone First, UPMC for You, and Geisinger Health Plan. Each MCO administers the PDL differently, but lisinopril's preferred status means your pharmacy claim should process without a step-therapy requirement at standard doses.

For patients with chronic kidney disease (CKD), lisinopril carries particular guideline support. The American Diabetes Association Standards of Care recommend ACE inhibitors as first-line agents for diabetic nephropathy [6]. Pennsylvania MA reimburses lisinopril for this indication without a separate PA request in most cases. Patients with documented heart failure with reduced ejection fraction (HFrEF) also receive lisinopril coverage; the drug is listed among guideline-directed medical therapy (GDMT) agents in the 2022 AHA/ACC Heart Failure Guidelines [7].

If your MCO does deny a claim, the Pennsylvania Pharmaceutical Assistance Contract for the Elderly (PACE) program may fill the gap for adults 65 and older with annual incomes at or below $33,500 (single) or $41,500 (married) as of 2025 figures [8]. PACENET extends eligibility to slightly higher income thresholds. Both programs can cover the copay or the entire cost depending on enrollment tier.

Which Insurance Plans Cover Lisinopril in Pennsylvania?

Most commercial insurance plans active in Pennsylvania place generic lisinopril on Tier 1 of their formulary, meaning it carries the lowest possible copay, typically $0, $10 per 30-day fill.

Major carriers in Pennsylvania that list lisinopril on Tier 1 include Independence Blue Cross, Highmark, UPMC Health Plan, and Aetna Pennsylvania products [9]. Employer-sponsored self-funded plans generally follow similar formulary structures, though the plan administrator sets the final tier placement.

For Medicare Part D enrollees in Pennsylvania, lisinopril appears on the formularies of most stand-alone Part D plans and Medicare Advantage plans with drug coverage. The Low Income Subsidy (LIS, also called Extra Help) reduces the Part D copay to $0, $4.15 per fill for qualifying enrollees [10]. Patients who do not qualify for LIS but are enrolled in a benchmark Part D plan may pay $0 copay on generic Tier 1 drugs.

Short-term health plans sold in Pennsylvania do not always include prescription drug coverage, so verify before assuming a plan covers lisinopril. ACA Marketplace plans sold on Pennie, Pennsylvania's state-based exchange, must cover essential health benefits, which include prescription drugs, and lisinopril consistently appears in the drug formularies of silver and gold tier plans [11].

Is Compounded Lisinopril Legal in Pennsylvania?

Compounded lisinopril prepared by a state-licensed 503A pharmacy is legal in Pennsylvania when a valid patient-specific prescription exists from a licensed prescriber. Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies, and Pennsylvania's State Board of Pharmacy enforces corresponding state regulations [12].

503A compounding pharmacies in Pennsylvania may prepare lisinopril in alternative dose forms, such as oral suspensions for patients who cannot swallow tablets, or in custom strengths not commercially available. A physician or nurse practitioner must issue a valid prescription specifying the patient, the drug, the strength, and the intended use before the pharmacy can compound the preparation [12].

Cost for compounded lisinopril depends on the indication and the prescriber's clinical judgment. For qualifying patients receiving compounded medications through certain patient assistance arrangements, the out-of-pocket cost can fall to $0 per month. That figure applies specifically to patients whose prescribers work with 503A pharmacies that operate affiliated assistance programs, not to all Pennsylvania residents.

503B outsourcing facilities operate under stricter FDA oversight and generally supply hospitals and clinics rather than individual patients. A Pennsylvania patient filling a retail prescription will almost always interact with a 503A pharmacy, not a 503B facility [13].

Compounded lisinopril is not FDA-approved and lacks the bioequivalence data that generic manufacturers must submit. The FDA has not placed lisinopril on its Difficult to Compound or Essentially a Copy lists as of mid-2025, meaning 503A pharmacies retain the legal authority to compound it with a valid prescription [13].

Can I Get a Lisinopril Prescription via Telehealth in Pennsylvania?

Telehealth prescribing of lisinopril is permitted in Pennsylvania. State law allows licensed Pennsylvania prescribers to evaluate patients via synchronous audio-video visits and issue prescriptions for non-controlled substances including lisinopril [14].

Pennsylvania's telehealth statute (Act 96 of 2020) does not require an in-person visit before a prescriber issues a prescription for a non-controlled medication, provided the prescriber can establish a valid patient-provider relationship through the telehealth encounter [14]. Lisinopril is not a controlled substance under Pennsylvania or federal law, so no additional DEA or state waiver is needed.

From a clinical workflow standpoint, a telehealth prescriber evaluating a patient for hypertension will typically request a recent blood pressure log, a basic metabolic panel (BMP) to assess serum potassium and creatinine, and a review of current medications before initiating lisinopril. The 2017 ACC/AHA Hypertension Guidelines define Stage 1 hypertension as a systolic blood pressure of 130 to 139 mmHg or diastolic 80 to 89 mmHg [15]. For patients in that range, ACE inhibitors including lisinopril are appropriate first-line choices, particularly in the presence of diabetes, CKD, or heart failure [15].

Monitoring after initiation remains important regardless of whether the prescription originated from a telehealth or in-person visit. A BMP to check potassium and creatinine at 1 to 2 weeks after starting lisinopril is standard practice because ACE inhibitors can cause hyperkalemia and a transient rise in serum creatinine [16].

What Discount Programs Lower Lisinopril Costs in Pennsylvania?

Several programs can cut lisinopril's already-low cash price further for Pennsylvania residents who pay out of pocket or face high copays.

GoodRx is available at every major Pennsylvania chain and many independents. Presenting a GoodRx coupon at a participating pharmacy has lowered the price of 30 tablets of lisinopril 10 mg to under $4 at multiple Pennsylvania ZIP codes based on 2026 pricing data [4]. RxSaver and Blink Health operate similarly, and prices may differ by a few cents to a dollar depending on the pharmacy.

NeedyMeds maintains a database of patient assistance programs (PAPs) for lower-income patients. While lisinopril's generic cost is already low, NeedyMeds lists state and nonprofit programs in Pennsylvania that may cover copays for patients on fixed incomes [17].

The Pennsylvania PACE and PACENET programs, administered by the Pennsylvania Department of Aging, cover prescription drug costs including lisinopril for eligible older adults [8]. Income limits update annually. Enrollment is free, and applications are accepted by mail or through county Area Agencies on Aging.

The federal Extra Help (Low Income Subsidy) program reduces or eliminates Part D drug costs for Medicare enrollees whose income and resources fall below specific thresholds. The Social Security Administration administers Extra Help, and Pennsylvania residents can apply directly at SSA.gov or through their local SHIP counselor [10].

The table below outlines a stepwise cost-reduction framework for Pennsylvania patients. A clinician reviewing this article can use it as a counseling guide:

Pennsylvania Lisinopril Cost-Reduction Framework (2026)

1. Confirm Medicaid or Medicare eligibility first. These pathways carry the lowest or zero copay for most patients.
2. If commercially insured, verify Tier 1 placement on your plan's 2026 formulary before filling; switch pharmacies in-network if needed.
3. If paying cash, run GoodRx and RxSaver quotes at three Pennsylvania ZIP codes near you before choosing a pharmacy.
4. If age 65 or older with limited income, apply to PACE or PACENET through the Pennsylvania Department of Aging before using a discount card.
5. If unable to swallow tablets or needing a non-standard strength, ask your prescriber whether a 503A compounding pharmacy is appropriate; confirm the pharmacy's Pennsylvania State Board of Pharmacy license before filling.
6. If a telehealth visit is needed to initiate or continue therapy, confirm the platform's prescriber is licensed in Pennsylvania and can transmit the prescription electronically to a Pennsylvania pharmacy.

How Does Lisinopril Work and Why Is It Prescribed?

Lisinopril inhibits angiotensin-converting enzyme, reducing circulating angiotensin II and aldosterone. The result is vasodilation and a drop in both systolic and diastolic blood pressure [2]. It also reduces proteinuria in diabetic nephropathy by lowering intraglomerular pressure, a mechanism the RENAAL trial (N=1,513) explored with the related agent losartan [18]. Lisinopril itself has been studied extensively in post-MI patients; the GISSI-3 trial (N=19,394) showed that lisinopril started within 24 hours of an acute MI reduced six-week mortality by 12% compared to control (odds ratio 0.88 to 95% CI 0.79, 0.99) [19].

The FDA-approved indications for lisinopril include hypertension in adults and pediatric patients 6 years and older, adjunctive treatment of stable heart failure, and treatment of hemodynamically stable patients within 24 hours of acute MI to improve survival [1]. Dosing for hypertension typically starts at 10 mg once daily and can be titrated to 40 mg once daily based on blood pressure response [1].

Common side effects include a dry cough, which occurs in approximately 10 to 15% of patients and results from bradykinin accumulation, and hyperkalemia, which is more common in patients with CKD or on concomitant potassium-sparing diuretics [16]. Angioedema is rare but serious; the FDA label carries a boxed warning for fetal toxicity and a contraindication in pregnancy [1].

The JNC 8 guideline panel recommended that adults with hypertension and CKD receive an ACE inhibitor or angiotensin receptor blocker regardless of race, given evidence for slowing CKD progression [20]. Pennsylvania clinicians following JNC 8 will often select lisinopril as the first ACE inhibitor because of its once-daily dosing, established trial record, and low generic cost.

What Is the Correct Lisinopril Dose for Hypertension?

The starting dose for hypertension in adults without volume depletion is 10 mg orally once daily. The FDA-approved label supports titration up to 40 mg once daily if blood pressure remains above goal at 2 to 4 weeks [1]. Patients with renal impairment (CrCl <30 mL/min) or those on dialysis start at 2.5 mg once daily [1].

For heart failure, the starting dose is 2.5 to 5 mg once daily, titrated toward a target of 20 to 40 mg daily as tolerated, consistent with the AHA/ACC Heart Failure Guidelines [7]. The ATLAS trial (N=3,164) compared low-dose (2.5 to 5 mg) with high-dose (32.5 to 35 mg) lisinopril in heart failure patients and found that high-dose therapy reduced the combined risk of death or hospitalization by 12% (P<0.001) [21].

Blood pressure response typically appears within one week of initiation and reaches a steady plateau by two to four weeks [2]. Clinicians should recheck a BMP at one to two weeks post-initiation to screen for hyperkalemia or a rise in creatinine exceeding 30% of baseline, which may indicate renovascular disease [16].

Monitoring and Safety Considerations for Pennsylvania Patients

Lisinopril is generally well tolerated at doses used for hypertension, but specific laboratory monitoring is standard of care. The American College of Cardiology recommends a baseline BMP and repeat testing at two to four weeks after initiation or dose titration of an ACE inhibitor [22].

Patients with CKD Stage 3b or higher (eGFR <45 mL/min/1.73 m²) require more frequent potassium monitoring because ACE inhibitor-related hyperkalemia risk rises as renal function declines [16]. Pennsylvania telehealth platforms that prescribe lisinopril should have a mechanism for ordering and reviewing labs electronically before and after prescribing.

Concurrent use of NSAIDs, including over-the-counter ibuprofen and naproxen, reduces lisinopril's antihypertensive effect and increases the risk of acute kidney injury [2]. Pennsylvania patients filling lisinopril at a retail pharmacy should receive pharmacist counseling on this interaction at the point of dispensing, consistent with Pennsylvania Board of Pharmacy counseling regulations.

Pregnancy is an absolute contraindication. The FDA label carries a boxed warning: lisinopril can cause fetal harm when administered to a pregnant woman, with documented cases of fetal renal dysplasia, oligohydramnios, and neonatal death [1]. Women of reproductive age in Pennsylvania receiving lisinopril should receive counseling about reliable contraception, consistent with the ACOG guidance on ACE inhibitor use in women of childbearing potential [23].

How Does Lisinopril Compare to Other Antihypertensives on Cost in Pennsylvania?

Generic lisinopril at $8 per month is among the cheapest antihypertensive options available at Pennsylvania pharmacies. Comparable ACE inhibitors such as enalapril and ramipril also sit in the $5, $12 per month cash-pay range. Angiotensin receptor blockers (ARBs) such as losartan generally cost $8, $15 per month generic in Pennsylvania.

Calcium channel blockers such as amlodipine can be found for $4, $8 per month cash-pay. Thiazide diuretics like hydrochlorothiazide or chlorthalidone often run $4, $7 per month. Beta-blockers such as metoprolol succinate ER cost $10, $20 per month depending on dose and formulation.

The ALLHAT trial found that chlorthalidone, lisinopril, and amlodipine performed similarly for the primary outcome of fatal coronary heart disease or nonfatal MI across 33,357 high-risk hypertensive adults over a mean follow-up of 4.9 years [3]. From a pure cost standpoint in Pennsylvania, the choice among these generics may come down to tolerability and comorbidities rather than price, since all fall within a few dollars of each other per month.